INR and COVID-19 severity and mortality: A systematic review with meta-analysis and meta-regression

Angelo Zinellu1, Panagiotis Paliogiannis2, Ciriaco Carru1

  • 1Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Insights

Elevated International Normalized Ratio (INR) levels are linked to increased severity and mortality in coronavirus disease 2019 (COVID-19) patients. This finding, alongside D-dimer, aids in diagnosing COVID-19 coagulopathy and predicting outcomes.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • D-dimer elevations indicate a pro-thrombotic state in COVID-19, predicting adverse outcomes.
  • The clinical significance of other coagulation markers, like the International Normalized Ratio (INR), in COVID-19 remains less understood.

Purpose of the Study:

  • To systematically review and meta-analyze the association between INR values and COVID-19 severity and mortality.
  • To evaluate the utility of INR as a predictor of clinical outcomes in COVID-19 patients.

Main Methods:

  • A comprehensive literature search was performed in PubMed, Web of Science, and Scopus from January 2020 to February 2021.
  • Included studies reported INR values, COVID-19 severity metrics, and mortality data.
  • Meta-analysis and meta-regression were used to synthesize findings and explore associations with other biomarkers.

Main Results:

  • Thirty-eight studies involving 7440 patients were analyzed.
  • Prolonged INR was significantly associated with severe COVID-19 and non-survivor status (SMD 0.60; 95% CI 0.42 to 0.77; p < 0.001).
  • INR showed significant associations with C-reactive protein and D-dimer levels in meta-regression.

Conclusions:

  • Prolonged INR values are significantly associated with increased COVID-19 severity and mortality.
  • Both INR prolongation and elevated D-dimer levels are valuable tools for diagnosing COVID-19-associated coagulopathy.
  • These markers can aid in predicting clinical outcomes for patients with COVID-19.
Abstract

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
208
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
50
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
69
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
143
Coefficient of Correlation01:12

Coefficient of Correlation

The correlation coefficient, r, developed by Karl Pearson in the early 1900s, is numerical and provides a measure of strength and direction of the linear association between the independent variable x and the dependent variable y.
If you suspect a linear relationship between x and y, then r can measure how strong the linear relationship is.
What the VALUE of r tells us:
The value of r is always between –1 and +1: –1 ≤ r ≤ 1.
The size of the correlation r indicates the...
6.9K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
102